219 related articles for article (PubMed ID: 25159123)
1. Biochemical evaluation of virtual screening methods reveals a cell-active inhibitor of the cancer-promoting phosphatases of regenerating liver.
Hoeger B; Diether M; Ballester PJ; Köhn M
Eur J Med Chem; 2014 Dec; 88():89-100. PubMed ID: 25159123
[TBL] [Abstract][Full Text] [Related]
2. Discovery and Evaluation of PRL Trimer Disruptors for Novel Anticancer Agents.
Bai Y; Yu ZH; Zhang ZY
Methods Mol Biol; 2016; 1447():121-38. PubMed ID: 27514804
[TBL] [Abstract][Full Text] [Related]
3. Identification of inhibitors of inositol 5-phosphatases through multiple screening strategies.
Pirruccello M; Nandez R; Idevall-Hagren O; Alcazar-Roman A; Abriola L; Berwick SA; Lucast L; Morel D; De Camilli P
ACS Chem Biol; 2014 Jun; 9(6):1359-68. PubMed ID: 24742366
[TBL] [Abstract][Full Text] [Related]
4. Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells.
Min G; Lee SK; Kim HN; Han YM; Lee RH; Jeong DG; Han DC; Kwon BM
Bioorg Med Chem Lett; 2013 Jul; 23(13):3769-74. PubMed ID: 23726031
[TBL] [Abstract][Full Text] [Related]
5. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
[TBL] [Abstract][Full Text] [Related]
6. Targeting phosphatases of regenerating liver (PRLs) in cancer.
Wei M; Korotkov KV; Blackburn JS
Pharmacol Ther; 2018 Oct; 190():128-138. PubMed ID: 29859177
[TBL] [Abstract][Full Text] [Related]
7. Procyanidins Negatively Affect the Activity of the Phosphatases of Regenerating Liver.
Stadlbauer S; Rios P; Ohmori K; Suzuki K; Köhn M
PLoS One; 2015; 10(7):e0134336. PubMed ID: 26226290
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1.
Bravo Y; Teriete P; Dhanya RP; Dahl R; Lee PS; Kiffer-Moreira T; Ganji SR; Sergienko E; Smith LH; Farquharson C; Millán JL; Cosford ND
Bioorg Med Chem Lett; 2014 Sep; 24(17):4308-11. PubMed ID: 25124115
[TBL] [Abstract][Full Text] [Related]
9. Virtual Screening with Docking Simulations and Biochemical Evaluation of VHY Phosphatase Inhibitors.
Park H; Lee HS; Kim SJ
Chem Pharm Bull (Tokyo); 2015; 63(10):807-11. PubMed ID: 26423037
[TBL] [Abstract][Full Text] [Related]
10. Identification of small molecule inhibitors of PTPσ through an integrative virtual and biochemical approach.
Martin KR; Narang P; Xu Y; Kauffman AL; Petit J; Xu HE; Meurice N; MacKeigan JP
PLoS One; 2012; 7(11):e50217. PubMed ID: 23185579
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel selective small-molecule inhibitor of protein arginine methyltransferase 5 (PRMT5) by virtual screening, resynthesis and biological evaluations.
Zhu K; Jiang C; Tao H; Liu J; Zhang H; Luo C
Bioorg Med Chem Lett; 2018 May; 28(9):1476-1483. PubMed ID: 29628326
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of thienopyridone and iminothienopyridinedione inhibition of protein phosphatases.
Zhang Z; Kozlov G; Chen YS; Gehring K
Medchemcomm; 2019 May; 10(5):791-799. PubMed ID: 31191869
[TBL] [Abstract][Full Text] [Related]
13. The dual inhibition against the activity and expression of tyrosine phosphatase PRL-3 from a rhodanine derivative.
Lin L; Lu L; Yuan C; Wang A; Zhu M; Fu X; Xing S
Bioorg Med Chem Lett; 2021 Jun; 41():127981. PubMed ID: 33766767
[TBL] [Abstract][Full Text] [Related]
14. Focused library with a core structure extracted from natural products and modified: application to phosphatase inhibitors and several biochemical findings.
Hirai G; Sodeoka M
Acc Chem Res; 2015 May; 48(5):1464-73. PubMed ID: 25894598
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo.
Grosskopf S; Eckert C; Arkona C; Radetzki S; Böhm K; Heinemann U; Wolber G; von Kries JP; Birchmeier W; Rademann J
ChemMedChem; 2015 May; 10(5):815-26. PubMed ID: 25877780
[TBL] [Abstract][Full Text] [Related]
16. High throughput screen identifies small molecule inhibitors specific for Mycobacterium tuberculosis phosphoserine phosphatase.
Arora G; Tiwari P; Mandal RS; Gupta A; Sharma D; Saha S; Singh R
J Biol Chem; 2014 Sep; 289(36):25149-65. PubMed ID: 25037224
[TBL] [Abstract][Full Text] [Related]
17. Discovery of potent inhibitors of receptor protein tyrosine phosphatase sigma through the structure-based virtual screening.
Park H; Chien PN; Ryu SE
Bioorg Med Chem Lett; 2012 Oct; 22(20):6333-7. PubMed ID: 22989533
[TBL] [Abstract][Full Text] [Related]
18. Integrating virtual and biochemical screening for protein tyrosine phosphatase inhibitor discovery.
Martin KR; Narang P; Medina-Franco JL; Meurice N; MacKeigan JP
Methods; 2014 Jan; 65(2):219-28. PubMed ID: 23969317
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity.
Peng C; Li YH; Yu CW; Cheng ZH; Liu JR; Hsu JL; Hsin LW; Huang CT; Juan HF; Chern JW; Cheng YS
Bioorg Chem; 2021 May; 110():104813. PubMed ID: 33774493
[TBL] [Abstract][Full Text] [Related]
20. The double lives of phosphatases of regenerating liver: A structural view of their catalytic and noncatalytic activities.
Gehring K; Kozlov G; Yang M; Fakih R
J Biol Chem; 2022 Jan; 298(1):101471. PubMed ID: 34890645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
